| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0019 | 0.9 |